Bio-Rad Laboratories (BIO) Revenue (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Revenue data on file, last reported at $592.1 million in Q1 2026.

• Revenue for Q1 2026 came in at $592.1 million, up 1.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 billion (up 1.92% YoY), and the FY2025 annual result was $2.6 billion, up 0.65% from the prior year.
• Revenue slipped to $592.1 million in Q1 2026 per BIO's latest filing, from $693.2 million in the prior quarter.
• Over five years, Revenue peaked at $730.3 million in Q4 2022 and troughed at $585.4 million in Q1 2025.
• A 5-year average of $659.7 million and a median of $667.5 million in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2024 and 2025: Revenue fell 9.75% in 2024, then climbed 3.85% in 2025.
• A 5-year view of Revenue shows it stood at $730.3 million in 2022, then declined by 6.72% to $681.2 million in 2023, then retreated by 2.01% to $667.5 million in 2024, then grew by 3.85% to $693.2 million in 2025, then fell by 14.58% to $592.1 million in 2026.
• Business Quant data shows BIO's Revenue at $592.1 million in Q1 2026, $693.2 million in Q4 2025, and $653.0 million in Q3 2025.